Abstract:Background Hepatocellular carcinoma (HCC) is one of the most prevalent and aggressive malignancies worldwide. Studies seeking to advance the overall understanding of lncRNA profiling in HCC remain rare. Methods The transcriptomic profiling of 12 HCC tissues and paired adjacent normal tissues was determined using high-throughput RNA sequencing. Fifty differentially expressed mRNAs (DEGs) and lncRNAs (DELs) were validated in 21 paired HCC tissues via quantitative real-time PCR. The correlation between the expression of DELs and various clinicopathological characteristics was analyzed using Student’s t -test or linear regression. Co-expression networks between DEGs and DELs were constructed through Pearson correlation co-efficient and enrichment analysis. Validation of DELs’ functions including proliferation and migration was performed via loss-of-function RNAi assays. Results In this study, we identified 439 DEGs and 214 DELs, respectively, in HCC. Furthermore, we revealed that multiple DELs, including NONHSAT003823, NONHSAT056213, NONHSAT015386 and especially NONHSAT122051, were remarkably correlated with tumor cell differentiation, portal vein tumor thrombosis, and serum or tissue alpha fetoprotein levels. In addition, the co-expression network analysis between DEGs and DELs showed that DELs were involved with metabolic, cell cycle, chemical carcinogenesis, and complement and coagulation cascade-related pathways. The silencing of the endogenous level of NONHSAT122051 or NONHSAT003826 could significantly attenuate the mobility of both SK-HEP-1 and SMMC-7721 HCC cells. Conclusion These findings not only add knowledge to the understanding of genome-wide transcriptional evaluation of HCC but also provide promising targets for the future diagnosis and treatment of HCC.

Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma

Functional long non-coding RNAs in hepatocellular carcinoma

Progress and Prospects of Long Noncoding RNAs (lncrnas) in Hepatocellular Carcinoma.

Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma

The Paradoxical Functions of Long Noncoding RNAs in Hepatocellular Carcinoma: Implications in Therapeutic Opportunities and Precision Medicine

Long Non-Coding RNAs As Biomarkers and Therapeutic Targets: Recent Insights into Hepatocellular Carcinoma.

Profiling, clinicopathological correlation and functional validation of specific long non-coding RNAs for hepatocellular carcinoma

Long non-coding RNAs in hepatocellular carcinoma

Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis

Long non-coding RNAs in hepatocellular carcinoma: Ordering of the complicated lncRNA regulatory network and novel strategies for HCC clinical diagnosis and treatment

Expression Levels of Lncrnas Are Prognostic for Hepatocellular Carcinoma Overall Survival.

The role of long noncoding RNAs in hepatocellular carcinoma.

Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials

Long Noncoding Rnas In Hepatocellular Carcinoma: Novel Insights Into Their Mechanism

Long Non-Coding RNAs: Critical Players in Hepatocellular Carcinoma

Research progresses of long noncoding RNA in hepatocellular carcinoma

The role of long non-coding RNA in hepatocellular carcinoma

[Research Advances in Diagnostic and Therapeutic Application of Long-Chain Non-Coding RNAs in Hepatocellular Carcinoma].

Advances in research of long noncoding RNAs in hepatic carcinoma

The Emergence of Long Non-Coding RNAs in Hepatocellular Carcinoma: an Update

Diagnosis, Prognosis and Bioinformatics Analysis of Lncrnas in Hepatocellular Carcinoma.